• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Nectar Lifesciences Limited — Board Meeting, 14-08-2026: Outcome of Board Meeting

    14-08-2026 | 08:46 pm

    Nectar Lifesciences announced Q1 consolidated net loss of ₹15.40 Cr, including a ₹25.13 Cr investment loss due to market volatility. The board approved results, appointed Dr. Gunmala Suri as a Director, and set the AGM for Sep 18. Company eyes real estate, actively monetizing assets.

    No comments yet. Be the first to comment!

    All announcements from Nectar Lifesciences Limited